Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of Cardiology and the American Heart Association to intervene on only the culprit vessel. Those patients undergoing multi-vessel intervention experience higher unadjusted morbidity/mortality than those patients undergoing single vessel PCI. However, multi-vessel PCI was not a significant predictor of mortality once co-morbid conditions were controlled in the regression model. These are among the findings of new research presented this week by Dr. Aaron D. Kugelmass of Baystate Medical Center at the American College of Cardiology's Scientific Sessions 2010 in Atlanta. Read the research at: http://tinyurl.com/ycue7xb.  

According to the study, STEMI patients undergoing multi-vessel PCI were more likely to be male, experience cardiogenic shock and have a drug-eluting stent. They also experience increased unadjusted in-hospital mortality, are more likely to experience Acute Renal Failure, and have a lower incidence of CABG than those undergoing single vessel PCI.

The research, funded and conducted by Cardiac Data Solutions, studied data on Medicare beneficiaries (MB) with a primary diagnosis of STEMI (first diagnosis code) that underwent a PCI during hospitalization between October 1, 2006 and September 30, 2007 and included 24,189 MB.

The study compared the following clinical outcomes between the MB undergoing single-vessel versus multi-vessel PCI:

  • Acute renal failure
  • New-onset hemodialysis
  • Any vascular complication
  • Observed mortality
  • Expected mortality
  • Stent type and usage

"The study supports the current recommendations that STEMI patients undergo culprit vessel PCI only, however, prospective assessment of this question is needed to identify the best treatment strategy for patients with STEMI and multi-vessel CAD," said April Simon, RN, MSN, president of Cardiac Data Solutions and one of the researchers.

Source:

Cardiac Data Solutions, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Medicare drug plans are getting better next year. some will also cost more.